These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A role for interleukins in ochronosis in a chondrocyte in vitro model of alkaptonuria. Mistry JB; Jackson DJ; Bukhari M; Taylor AM Clin Rheumatol; 2016 Jul; 35(7):1849-56. PubMed ID: 26474772 [TBL] [Abstract][Full Text] [Related]
26. A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria. Spiga O; Cicaloni V; Zatkova A; Millucci L; Bernardini G; Bernini A; Marzocchi B; Bianchini M; Zugarini A; Rossi A; Zazzeri M; Trezza A; Frediani B; Ranganath L; Braconi D; Santucci A Comput Biol Med; 2018 Dec; 103():1-7. PubMed ID: 30316064 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. Tinti L; Spreafico A; Braconi D; Millucci L; Bernardini G; Chellini F; Cavallo G; Selvi E; Galeazzi M; Marcolongo R; Gallagher JA; Santucci A J Cell Physiol; 2010 Oct; 225(1):84-91. PubMed ID: 20648626 [TBL] [Abstract][Full Text] [Related]
29. [Knee ochronotic arthropathy and arthroscopic findings]. Kural C; Cetinus EM; Kural A; Uğraş AA; Kaya I Acta Orthop Traumatol Turc; 2009; 43(1):67-71. PubMed ID: 19293619 [TBL] [Abstract][Full Text] [Related]
30. Analysis of Melanin-like Pigment Synthesized from Homogentisic Acid, with or without Tyrosine, and Its Implications in Alkaptonuria. Taylor AM; Vercruysse KP JIMD Rep; 2017; 35():79-85. PubMed ID: 27943071 [TBL] [Abstract][Full Text] [Related]